Please scroll down to bottom of email to add or remove your name from the IAS mailing list.

International Atherosclerosis
Society
e-Newsletter
April 2008

 


Back to IAS Home Page

www.athero.org






 

Featured IAS Commentaries

These Commentaries, including all information, text, graphics, images, and other material are for general educational purposes only and are not intended to be used for the purposes of providing medical treatment or attention or making medical or health-related decisions. These Commentaries are not a substitute or replacement for medical advice. If you are seeking medical advice, we encourage you to consult a physician or other medical professional. The views expressed in these Commentaries are those of the authors and are not necessarily those of IAS.

Aging, Insulin Resistance, and Cognition
Author: Ahmet Turan Isik, M.D.

As the world population has aged, dementia has become a common diagnosis in aging populations and the numbers will increase in the forthcoming years. Now in the US about 4.5 million people are affected by Alzheimer’s disease (AD) alone. It is important for clinicians to recognize early signs and symptoms of dementia and to note potentially modifiable risk factors and early disease markers.

View Abstract


The Sphingolipid Analogue FTY720 (Fingolimod) Interferes with Cholesterol Metabolism and Lymphocyte Homeostasis in Apolipoprotein E-Deficient Mice
Author: Roland Klingenberg, M.D.

Sphingolipid signaling and metabolism have attracted considerable interest in vascular biology in the recent past. Sphingolipids colocalize with cholesterol in plasma membrane microdomains (lipid rafts) and are involved in key cellular functions such as cell proliferation and apoptosis, cell differentiation, cell migration, and immunological responses. Sphingosine constitutes the common backbone of several distinct sphingolipid species. Bioactive sphingosine-1-phosphate (S1P) promotes distinct effects via binding to G-protein coupled surface receptors (S1P1-5 receptors) comprising modulation of immune cell migration, macrophage differentiation, angiogenesis, vascular integrity, and enhancing eNOS-induced vasodilatation [1-3].

View Abstract


An Intriguing Genetic Association between a Tumor Suppressor Locus, Coronary Artery Disease and Diabetes
Author: M. Farrall

Cases of coronary artery disease (CAD) often cluster in families which, backed up by concordance studies of monozygous and dizygous twins, supports the hypothesis that CAD is a multifactorial condition with an important heritable component. Researchers have subsequently expended much effort in attempts to map specific variants that influence susceptibility to CAD, mostly through the application of the “candidate gene” paradigm. Recent advances in genotyping technology that facilitate the study of hundreds of thousands of genetic markers allow geneticists to greatly expand the scope of their searches for susceptibility genes.

> Read entire commentary


Apolipoprotien(a) Isoforms and Lipoprotein(a) as Risk Factors for Atherosclerosis
Authors: K. Tosheska, D. Labudovic, S. Alabakovska, M. Spiroski, B. Todorova

A detailed study of specific lipoprotein parameters is necessary in individuals at high risk of coronary heart disease (CHD). During the last two decades, attention has been focused on identification of new risk factors (such as genetic risk factors) in these individuals. One potential risk factor that has been extensively studied is lipoprotein(a) [Lp(a)]. It is well documented, that Lp(a) accumulates in the arterial wall at the sites of atherosclerotic lesions [1].

> Read entire commentary